These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19304137)

  • 1. Experience of appendicular thermal therapy applied to a patient with a left ventricular assist device awaiting heart transplantation.
    Higashi H; Komamura K; Oda N; Kato TS; Yanase M; Mano A; Hashimoto S; Wada K; Shishido T; Hashimura K; Kitakaze M; Kitamura S; Nakatani T
    J Cardiol; 2009 Apr; 53(2):301-5. PubMed ID: 19304137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Appendicular thermal therapy for heart failure].
    Komamura K
    Nihon Rinsho; 2009 Mar; 67(3):637-43. PubMed ID: 19280944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.
    Fieno DS; Czer LS; Schwarz ER; Simsir S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):919-20. PubMed ID: 19706718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch from assist device to total artificial heart to improve cardiac output.
    Sindermann JR; Hoffmeier A; Tjan TD; Scheld HH
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):52-3. PubMed ID: 19170000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada.
    Carrier M; Perrault LP; Bouchard D; Pellerin M; Racine N; White M; Pelletier G
    Can J Cardiol; 2004 Apr; 20(5):501-4. PubMed ID: 15100751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
    J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.
    Assad-Kottner C; Chen D; Jahanyar J; Cordova F; Summers N; Loebe M; Merla R; Youker K; Torre-Amione G
    J Card Fail; 2008 Dec; 14(10):839-43. PubMed ID: 19041047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The left ventricular assist device (LVAD). A bridge to heart transplantation.
    Camp D
    Crit Care Nurs Clin North Am; 2000 Mar; 12(1):61-8. PubMed ID: 11051919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.